Literature DB >> 15760102

Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII).

Shan-Yang Lin1, Kung-Hsu Lin, Mei-Jane Li.   

Abstract

The dry-coated tablet with optimal lag time was designed to simulate the dosing time of drug administration according to the physiological needs. Different compositions of ethylcellulose (EC) powder with a coarse particle (167.5 microm) and several fine particles (< 6 microm), respectively, were mixed to formulate the whole layer of the outer shell of dry-coated tablets. The formulations containing different weight ratios of coarse/fine particles of EC powders or 167.5 microm EC powder/excipient in the upper layer of the outer shell to influence the release behavior of sodium diclofenac from dry-coated tablet were also explored. The results indicate that sodium diclofenac released from all the dry-coated tablets exhibited an initial lag period, followed by a stage of rapid drug release. When the mixture of the coarse/fine particles of EC powders was incorporated into the whole layer, the lag time was almost the same. The outer shell broke into 2 halves to make a rapid drug release after the lag time, which belonged to the time-controlled disruption of release mechanism. When the lower layer in the outer shell was composed of 167.5 microm EC powder and the upper layer was formulated by mixing different weight ratios of 167.5 microm and 6 microm of EC powders, the drug release also exhibited a time-controlled disruption behavior. Its lag time might be freely modulated, depending on the amount of 6 microm EC powder added. Once different excipients were respectively incorporated into the upper layer of the outer shell, different release mechanisms were observed as follows: time-controlled explosion for Explotab, disruption for Avicel and spray-dried lactose, erosion for dibasic calcium phosphate anhydrate, and sigmoidal profile for hydroxypropyl methylcellulose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760102      PMCID: PMC2751242          DOI: 10.1208/aapsj060317

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  20 in total

1.  Controlled release technologies for drug delivery.

Authors:  David J Brayden
Journal:  Drug Discov Today       Date:  2003-11-01       Impact factor: 7.851

2.  Influence of internal structure on kinetics of drug release from wax matrix tablets.

Authors:  R Ishino; H Yoshino; Y Hirikawa; K Noda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-12       Impact factor: 1.645

3.  Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.

Authors:  G Paolisso; A J Scheen; D Giugliano; S Sgambato; A Albert; M Varricchio; F D'Onofrio; P J Lefèbvre
Journal:  J Clin Endocrinol Metab       Date:  1991-03       Impact factor: 5.958

4.  The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.

Authors:  J Z Li; G S Rekhi; L L Augsburger; R F Shangraw
Journal:  Pharm Dev Technol       Date:  1996-12       Impact factor: 3.133

5.  Effect of diluents on tablet integrity and controlled drug release.

Authors:  Y E Zhang; J B Schwartz
Journal:  Drug Dev Ind Pharm       Date:  2000-07       Impact factor: 3.225

6.  A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.

Authors:  D H Smith; J M Neutel; M A Weber
Journal:  Am J Hypertens       Date:  2001-01       Impact factor: 2.689

Review 7.  Clinical chronobiology and chronotherapeutics with applications to asthma.

Authors:  M H Smolensky; A E Reinberg; R J Martin; E Haus
Journal:  Chronobiol Int       Date:  1999-09       Impact factor: 2.877

8.  Relationship between particle packing and the physical stability of powder mixes.

Authors:  J N Staniforth
Journal:  J Pharm Pharmacol       Date:  1985-10       Impact factor: 3.765

Review 9.  Pharmacokinetic characterisation of transdermal delivery systems.

Authors:  B Berner; V A John
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

10.  Preparation and evaluation of sodium diclofenac controlled-release tablets. II. Dibasic calcium phosphate as a retardant in mixtures for direct compression.

Authors:  S Y Lin; C L Cheng; P C Lin
Journal:  Pharm World Sci       Date:  1995-03-24
View more
  2 in total

1.  Comparative study of in vitro release and mucoadhesivity of gastric compacts composed of multiple unit system/bilayered discs using direct compression of metformin hydrochloride.

Authors:  Mitra Jelvehgari; Parvin Zakeri-Milani; Fatemeh Khonsari
Journal:  Bioimpacts       Date:  2014-03-12

2.  Comparison of microencapsulation by emulsion-solvent extraction/evaporation technique using derivatives cellulose and acrylate-methacrylate copolymer as carriers.

Authors:  Mitra Jelvehgari; Seyed Hassan Montazam
Journal:  Jundishapur J Nat Pharm Prod       Date:  2012-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.